Financhill
Sell
28

CYTK Quote, Financials, Valuation and Earnings

Last price:
$33.93
Seasonality move :
7.33%
Day range:
$32.64 - $34.41
52-week range:
$29.31 - $61.38
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
207.31x
P/B ratio:
61.87x
Volume:
1.6M
Avg. volume:
2.1M
1-year change:
-34.78%
Market cap:
$4.1B
Revenue:
$18.5M
EPS (TTM):
-$5.29

Earnings Data

Next earnings date for CYTK
Aug 08
2025
Most recent earnings per share
-$1.36
Beat by $0.00
(May 6/2025)
Consensus Estimate
-$1.36
(May 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CYTK Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/08/2025 Q2 $1.9M -- -- -$1.35 --
05/06/2025 Q1 $2.6M $1.6M -$1.36 -$1.36 $0.00
02/27/2025 Q4 $14.3M $16.9M -$1.26 -$1.17 -$0.09
11/06/2024 Q3 $1.2M $463K -$1.36 -$1.24 -$0.12
08/08/2024 Q2 $21M $249K -$1.31 -$0.91 -$0.40
05/08/2024 Q1 $906.6K $835K -$1.33 -$1.17 -$0.16
02/27/2024 Q4 $13.3M $1.7M -$1.38 -$0.95 -$0.43
11/02/2023 Q3 -- -- -$1.35 -$0.76 -$0.59
08/03/2023 Q2 -- -- -$1.34 -$1.24 -$0.10
05/04/2023 Q1 -- -- -$1.38 -$1.18 -$0.20
03/01/2023 Q4 -- -- -$1.45 -$1.19 -$0.26
11/03/2022 Q3 -- -- -$1.52 -$1.17 -$0.35
08/04/2022 Q2 -- -- -$0.23 -$1.01 $0.78
05/04/2022 Q1 -- -- -$1.05 -$0.94 -$0.11
02/24/2022 Q4 -- -- -$0.36 -$0.84 $0.48
11/03/2021 Q3 -- -- -$0.95 -$0.77 -$0.18
08/05/2021 Q2 -- -- -$0.86 -$0.66 -$0.20
05/06/2021 Q1 -- -- -$0.66 -$0.61 -$0.05
02/25/2021 Q4 -- -- -$0.62 -$0.46 -$0.16
11/04/2020 Q3 -- -- -$0.05 -$0.34 $0.29
08/06/2020 Q2 -- -- -$0.68 -$0.57 -$0.11
05/06/2020 Q1 -- -- -$0.66 -$0.51 -$0.15
03/03/2020 Q4 -- -- -$0.51 -$0.44 -$0.07
10/31/2019 Q3 -- -- -$0.50 -$0.49 -$0.01
08/08/2019 Q2 -- -- -- -$0.50 --
05/09/2019 Q1 -- -- -- -$0.47 --
02/21/2019 Q4 -- -- -- -$0.52 --
11/01/2018 Q3 -- -- -- -$0.52 --
07/26/2018 Q2 -- -- -- -$0.51 --
04/26/2018 Q1 -- -- -- -- --
02/15/2018 Q4 -- -- -- -- --
10/26/2017 Q3 -- -- -- -- --
08/02/2017 Q2 -- -- -- -- --
04/27/2017 Q1 -- -- -- -- --
02/16/2017 Q4 -- -- -- -- --
10/27/2016 Q3 -- -- -- -- --
07/28/2016 Q2 -- -- -- -- --
04/28/2016 Q1 -- -- -- -- --
02/16/2016 Q4 -- -- -- -- --
10/29/2015 Q3 -- -- -- -- --
07/29/2015 Q2 -- -- -- -- --

Cytokinetics Earnings Questions

  • How Much did Cytokinetics Generate in Revenue Last Quarter?

    Cytokinetics reported $1.6M worth of top line sales in its most recent quarter.

  • Did Cytokinetics Beat Earnings Last Quarter?

    Cytokinetics announced earnings per share of -$1.36 which represents a beat of analyst forecast a -$1.36 per share.

  • Is Cytokinetics Profitable?

    Cytokinetics reported -$98.3M that represents -$0.83 per share over the last quarter.

  • What is the Analyst Consensus for Cytokinetics EPS Next Year?

    Cytokinetics's earnings are forecast to decrease from -$5.26 per share to -$5.16 per share next year representing a decrease of -9.11%.

  • When is Cytokinetics's Earnings Date?

    Cytokinetics's next earnings date is August 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will AST SpaceMobile Be In 5 Years?
Where Will AST SpaceMobile Be In 5 Years?

Ever tried to send a text from the Nevada desert…

Is TTD The Big Winner If Pharma Ads Are Banned?
Is TTD The Big Winner If Pharma Ads Are Banned?

Last week, Senators Bernie Sanders and Angus King introduced a…

Is Palantir Stock Overvalued?
Is Palantir Stock Overvalued?

By every traditional yardstick, including a price‑to‑sales well above 100,…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 48x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Sell
11
VEON alert for Jun 16

VEON [VEON] is up 5.03% over the past day.

Buy
74
DAVE alert for Jun 16

Dave [DAVE] is up 3.55% over the past day.

Buy
54
DAR alert for Jun 16

Darling Ingredients [DAR] is up 7.5% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock